四川大学华西医院肝脏外科研究室
|
|
发表文章：
1. Le Luo#, Yutong Yao#, Haotian Liao#, Jiwei Huang, Mingheng Liao, Jinju Wang, Kefei Yuan, Yong Zeng. Cumulative damage effect of jaundice may be an effective predictor of complications in patients undergoing radical resection of Bismuth type II or above hilar cholangiocarcinoma. Annals of Translational Medicine. 2021 May;9(10):861. (IF=3.934)
2. Hui Li#, Junlong Dai#, Tian Lan#, Hailing Liu, Jinju Wang, Bole Cai, Lin Xu, Kefei Yuan*, Genshu Wang*, Hong Wu*. Combination of albumin-globulin score and skeletal muscle index predicts long-term outcomes of intrahepatic cholangiocarcinoma patients after curative resection. Clinical Nutrition. 2021 Jun;40(6):3891-3900. (IF=7.320)
3. Tian Lan#, Hui Li#, Delin Zhang#, Lin Xu, Hailing Liu, Xiangyong Hao, Xiaokai Yan, Haotian Liao, Xiangzheng Chen, Kunlin Xie, Jiaxin Li, Mingheng Liao, Jiwei Huang, Kefei Yuan*, Yong Zeng* and Hong Wu*.KIAA1429 contributes to liver cancer progression through N6-methyladenosine dependent post-transcriptional modification of GATA3. Molecular Cancer, 2019; 18(1):186.(IF=15.302)
4. Kefei Yuan#, Kunlin Xie#, Tian Lan#, Lin Xu, Xiangzheng Chen, Xuefeng Li, Mingheng Liao, Jiaxin Li, Jiwei Huang, Yong Zeng*, Hong Wu*. TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin. Cell Death & Differentiation, 2020; 27(4):1355-1368.(IF=10.717)
5. Jiwei Huang, …, Yong Zeng*. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Annals of Surgery, 2010; 252(6):903-912. (IF=10.13 ESI高被引论文，引用次数474次)
6. Tian Lan#, Kefei Yuan#, Xiaokai Yan, Lin Xu, Haotian Liao, Xiangyong Hao, Jinju Wang, Hong Liu, Xiangzheng Chen, Kunlin Xie, Jiaxin Li, Mingheng Liao, Jiwei Huang, Yong Zeng* and Hong Wu*. LncRNA SNHG10 Facilitates Hepatocarcinogenesis and Metastasis by Modulating Its Homolog SCARNA13 via a Positive Feedback Loop. Cancer Research, 2019; 79(13):3220-3234.(IF=9.727, ESI高被引论文)
7. Hongjie Ji#, Yongjie Zhou#, Xiang Zhuang, Yongjie Zhu, Zhenru Wu, Yanrong Lu, Shengfu Li, Yong Zeng, Qing R. Lu, Yanying Huo, Yujun Shi*, Hong Bu. HDAC3 deficiency promotes liver cancer through a defect in H3K9ac/H3K9me3 transition. Cancer Research, 2019; 79(14):3676-3688.(IF=9.727)
8. Jia-Yan Huang, Jia-Wu Li, Qiang Lu*, Yan Luo, Ling Lin, Yu-Jun Shi, Tao Li, Ji-Bin Liu, Andrej Lyshchik.Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma. Radiology, 2020; 294(2):329-339.(IF=7.931)
9. Xu-Feng Lu#, Xiao-Yue Cao#, Yong-Jie Zhu, Zhen-Ru Wu, Xiang Zhuang, Ming-Yang Shao, Qing Xu, Yong-Jie Zhou, Hong-Jie Ji, Qing-Richard Lu, Yu-Jun Shi*, Yong Zeng and Hong Bu. Histone deacetylase 3 promotes liver regeneration and liver cancer cells proliferation through signal transducer and activator of transcription 3 signaling pathway.Cell Death and Disease, 2018; 9(3):398.(IF=6.304)
10. Hong Liu*, Wenzhu Lu, Hongbo He, Jin Wu, Caiguo Zhang*, Hanlin Gong and Chunmei Yang.Inflammation-dependent overexpression of c-Myc enhances CRL4DCAF4 E3 ligase activity and promotes ubiquitination of ST7 in colitis-associated cancer.Journal of Pathology, 2019; 248(4):464-475.(IF=5.979)
11. Li Wei#, Zhang Delin#, Yuan Kefei, Wu Hong, Huang Jiwei, and Zhang Yange*.A classification based on tumor budding and immune score for patients with hepatocellular carcinoma. Oncoimmunology, 2019; 9(1):1672495.(IF=5.869)
12. Kunlin Xie#, Lin Xu#, Hao Wu#, Haotian Liao, Lin Luo, Mingheng Liao, Jianping Gong, Yang Deng, Kefei Yuan*, Hong Wu* and Yong Zeng*.OX40 expression in hepatocellular carcinoma is associated with a distinct immune microenvironment, specific mutation signature, and poor prognosis. Oncoimmunology, 2018; 7(4):e1404214.(IF=5.869)
13. Haotian Liao#, Mingheng Liao#, Lin Xu, Xiaokai Yan, Bo Ren, Zexin Zhu, Kefei Yuan*, Yong Zeng*.Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma. EBioMedicine, 2019; 41:310-319.(IF=5.736)
14. Wei Li#, Lin Xu#, Jun Han#, Kefei Yuan* and Hong Wu*.Identification and Validation of Tumor Stromal Immunotype in Patients With Hepatocellular Carcinoma.Frontiers in Oncology, 2019; 9:664.(IF=4.848)
15. Hui Li#, Jiaxin Li#, Jinju Wang#, Hailing Liu, Bole Cai , Genshu Wang* and Hong Wu*.Assessment of Liver Function for Evaluation of Long-Term Outcomes of Intrahepatic Cholangiocarcinoma: A Multi-Institutional Analysis of 620 Patients. Frontiers in Oncology, 2020; 10:525.(IF=4.848)
16. Haotian Liao, Wen Chen, Yunlu Dai , JJ Richardson, Kunlin Xie, Junling Guo*, Kefei Yuan*, Yong Zeng*.Expression of programmed cell death-ligands in hepatocellular carcinoma: correlation with immune microenvironment and survival outcomes.Frontiers in Oncology, 2019; 9:883.(IF=4.848)
17. Hui Li#, Jinju Wang#, Hailing Liu#, Tian Lan, Lin Xu, Genshu Wang, Kefei Yuan*, Hong Wu*.Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early stage hepatocellular carcinoma. Aging, 2020; 12(4):3451-3472.(IF=4.831)
18. Wei Li, Jun Han, Kefei Yuan, Hong Wu*.Integrated tumor stromal features of hepatocellular carcinoma reveals two distinct subtypes with prognostic/predictive significance.Aging, 2019; 11(13):4478-4509.(IF=4.831)
19. Zheng Ye, Hanyu Jiang, Jie Chen, Xijiao Liu, Yi Wei, Chunchao Xia, Ting Duan, Likun Cao, Zhen Zhang, Bin Song*. Texture analysis on gadoxetic acid enhanced-MRI for predicting Ki-67 status in hepatocellular carcinoma: A prospective study. Chinese Journal of Cancer Research, 2019; 31(5):806-817.(IF=4.135)
20. Tianying Zheng#, Hanyu Jiang#, Yi Wei, Zixing Huang, Jie Chen, Ting Duan, Bin Song*. Imaging evaluation of sorafenib for treatment of advanced hepatocellular carcinoma. Chinese Journal of Cancer Research, 2018; 30(3):382-394.(IF=4.135)
21. Yi Wei#, Zixing Huang#, Hehan Tang, Liping Deng, Yuan Yuan, Jiaxing Li, Dongbo Wu, Xiaocheng Wei, Bin Song*.IVIM improves preoperative assessment of microvascular invasion in HCC. European Radiology, 2019; 29(10):5403-5414.(IF=4.101)
22. Jie Chen#, Zhenru Wu#, Chunchao Xia, Hanyu Jiang, Xijiao Liu, Ting Duan, Likun Cao, Zheng Ye, Zhen Zhang, Ling Ma, Bin Song*, Yujun Shi*.Noninvasive prediction of HCC with progenitor phenotype based on gadoxetic acid-enhanced MRI. European Radiology, 2020; 30(2):1232-1242.(IF=4.101)
23. Yi Wei#, Feifei Gao#, Min Wang, Zixing Huang, Hehan Tang, Jiaxing Li, Yi Wang, Tong Zhang, Xiaocheng Wei, Dandan Zheng, Bin Song*.Intravoxel incoherent motion diffusion-weighted imaging for assessment of histologic grade of hepatocellular carcinoma: comparison of three methods for positioning region of interest. European Radiology, 2019; 29(2):535-544. (IF=4.101)
24. Hai-Feng Wan#, Kun-Lin Xie#, Jia-Xin Li, Kit-Man Ho, Hong Wu*, and Ji-Wei Huang*.Laparoscopic Caudate Lobectomy for Cholangiocarcinoma of Caudate Lobe Invading Middle Hepatic Vein. Annals of Surgical Oncology, 2020; Online ahead of print.(IF=4.061)
25. Haotian Liao#, Zhen Zhang#, Jie Chen, Mingheng Liao, Lin Xu, Zhenru Wu, Kefei Yuan, Bin Song* and Yong Zeng*.Preoperative Radiomic Approach to Evaluate Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma Patients Using Contrast-Enhanced Computed Tomography. Annals of Surgical Oncology, 2019; 26(13):4537-4547.(IF=4.061)
26. Hao-Tian Liao, Ji-Wei Huang, Tian Lan, Jin-Ju Wang, Bo Zhu, Ke-Fei Yuan* and Yong Zeng*.Identifcation of The Aberrantly Expressed LncRNAs in Hepatocellular Carcinoma: A Bioinformatics Analysis Based on RNA-sequencing. Scientific Reports, 2018; 8(1):5395.(IF=3.998)
27. Yi Wei, Guoyong Chen, Hehan Tang, Yuan Yuan, Zixing Huang, Xiaopeng He, Zheng Ye, Tong Zhang, Xiaocheng Wei and Bin Song*. Improved Display of Hepatic Arterial Anatomy Using Differential Subsampling With Cartesian Ordering (DISCO) With Gadoxetic Acid-Enhanced MRI: Comparison With Single Arterial Phase MRI and Computed Tomographic Angiography. Journal of Magnetic Resonance Imaging, 2020; 51(6):1766-1776.(IF=3.954)
28. Jin-Ju Wang, Hui Li, Jia-Xin Li, Lin Xu, Hong Wu, Yong Zeng*.Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma ents following hepatic resection. World Journal of Gastroenterology, 2019; 26(13):4537-4547.(IF=3.665)
29. Tong Zhang, Zi-Xing Huang, Yi Wei, Han-Yu Jiang, Jie Chen, Xi-Jiao Liu, Li-Kun Cao, Ting Duan, Xiao-Peng He, Chun-Chao Xia, Bin Song*.Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy? World Journal of Gastroenterology, 25(5):622-631.(IF=3.665)
30. Han-Yu Jiang, Jie Chen, Chun-Chao Xia, Li-Kun Cao, Ting Duan, Bin Song*.Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis. World Journal of Gastroenterology, 2018; 24(22):2348-2362.(IF=3.665)
31. Wei Li, Long Li, Daniil Minigalin and Hong Wu*. Anatomic mesohepatectomy versus extended hepatectomy for patients with centrally located hepatocellular carcinoma. HPB, 2018; 20(6):530-537.(IF=3.401)
32. Ze-xin Zhu, Xiao-xue Wang, Ke-fei Yuan*, Ji-wei Huang* and Yong Zeng*. Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis. HPB, 2018; 20(9):795-802.(IF=3.401)
33. Hui Li, Bo Zhu, Jin Huang, Xing Chen, Jinju Wang and Hong Wu.Liver hanging maneuver versus conventional approach for open hepatectomy: a meta-analysis. HPB, 2019; 21(7):802-809.(IF=3.401)
34. Bo Zhu, Jinju Wang, Hui Li, Xing Chen and Yong Zeng*. Living or deceased organ donors in liver transplantation for hepatocellular carcinoma: a systematic review and meta-analysis. HPB, 2019; 21(2):133-147.(IF=3.401)
35. Yang Xiao, Wei Li, Haifeng Wan, Yifei Tan, Hong Wu*. Central hepatectomy versus major hepatectomy for patients with centrally located hepatocellular carcinoma: A meta-analysis. International Journal of Surgery, 2018; 52:297-302.(IF=3.357) 36. Jun Zhang, Zixing Huang, Likun Cao, Zhen Zhang, Yi Wei, Xin Zhang, Bin Song*.Differentiation combined hepatocellular and cholangiocarcinoma from intrahepatic cholangiocarcinoma based on radiomics machine learning. Annals of Translational Medicine, 2020; 8(4):119.(IF=3.297) 37. Likun Cao, Jie Chen, Ting Duan, Min Wang, Hanyu Jiang, Yi Wei, Chunchao Xia, Xiaoyue Zhou, Xu Yan, Bin Song*. Diffusion kurtosis imaging (DKI) of hepatocellular carcinoma:correlation with microvascular invasion and histologic grade. Quantitative Imaging in Medicine and Surgery, 2019; 9(4):590-602.(IF=3.226) 38. Haichuan Wang#, Hui Cao#, Zhong Xu, Dong Wang and Yong Zeng*. SNP rs2596542G>A in MICA is associated with risk of hepatocellular carcinoma: a meta-analysis. Bioscience Reports, 2019; 39(5):BSR20181400.(IF=2.942) 39. Hui Li, Jin-Ju Wang, Min Zhang, Bo Ren, Jia-Xin Li, Lin Xu, Hong Wu*.Prognostic significance of systemic immune-inflammation index in patients with intrahepatic cholangiocarcinoma undergoing hepatic resection. World Journal of Gastrointestinal Oncology, 2020; 12(4):467-482(IF=2.898) 40. Xiaokai Yan#, Haifeng Wan, Xiangyong Hao, Tian Lan, Wei Li, Lin Xu, Kefei Yuan#, Hong Wu*. Importance of gene expression signatures in pancreatic cancer prognosis and the establishment of a prediction model. Cancer Management and Research, 2018; 11:273-83.(IF=2.886) 41. Yong-Jie Zhu, Qing Xu, Ming-Yang Shao, Xiao-Yue Cao, Zhen-Ru Wu, Yu-Wei Chen, Hong Bu, Yu-Jun Shi*. Decreased expression of HDAC8 indicates poor prognosis in patients with intrahepatic cholangiocarcinoma. Hepatobiliary & Pancreatic Diseases International, 2019; 18(5):464-470. (IF=2.428) 42. Xiao-Yue Cao, Hong-Jie Ji, Yong-Jie Zhou, Xu-Feng Lu, Jun-Yi Shen, Zhen-Ru Wu, Hong Bu and Yu-Jun Shi*. Elevated expression of Gsαin intrahepatic cholangiocarcinoma associates with poor prognosis. Hepatobiliary & Pancreatic Diseases International, 2017;16(6):638-644.(IF=2.428) 43. Zhen Zhang#, Hanyu Jiang#, Jie Chen, Yi Wei, Likun Cao, Zheng Ye, Xin Li, Ling Ma and Bin Song*. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction. Cancer Imaging, 2019; 19(1):22.(IF=2.193) 44. Mingheng Liao, Zexin Zhu, Haichuan Wang , Jiwei Huang*. Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis. Scandinavian Journal of Gastroenterology, 2017; 52(6-7):624-634.(IF=2.13) 45. Hai-Feng Wan#, Jia-Xin Li#, Hao-Tian Liao#, Ming-Heng Liao, Lin Luo, Lin Xu, Ke-Fei Yuan*, Yong Zeng*. Nicotinamide induces liver regeneration and improves liver function by activating SIRT1. Mol Med Rep, 2019; 19: 555-562. (IF=2.1) 46. Lin Luo, Ze-Ping Yu, Han Qin, Ze-Xin Zhu, Ming-Heng Liao, Hao-Tian Liao, Ke-Fei Yuan*, Yong Zeng*. Exosomal MicroRNA-10a Is Associated with Liver Regeneration in Rats through Downregulation of EphA4.Chinese Medical Journal, 2018; 131(4):454-460.(IF=1.585) 47. Hong Liu, Chunmei Yang, Wenzhu Lu, Yong Zeng*. Prognostic significance of glypican-3 expression in hepatocellular carcinom A meta-analysis. Medicine, 2017; 97(4):e9702. (IF=1.552) 48. Yan Liu, Qiang Lu*, MD, Xiao-Li Wu, Guo-Ju Shen, Tao Luo. Ultrasonographic imaging of calcifying fibrous tumor of cervical esophagus. Medicine, 2019; 98(28):e16425.(IF=1.552) 49. Liao HT, Tan P, Huang JW*, Yuan KF*. Ledipasvir + Sofosbuvir for Liver Transplant Recipients With Recurrent Hepatitis C: A Systematic Review and Meta-analysis. Transplantation Proceedings, 2017; 49: 1855-63. (IF=0.784) 50. 金玉梅，宋彬，黄子星。肝细胞癌微血管侵犯的分子影像学研究进展。中国普外基础与临床杂志， 2019年5月；第26卷第5期. 51. 张珍，曲亚莉，宋彬。磁共振弹性成像在慢性肝脏疾病中的技术及应用进展。中国普外基础与临床杂志，2018年3月；第25卷第3期. 52. 曾 勇，杨家印，廖明恒，吴 泓。腹腔镜活体肝移植供肝切取关键技术。中国实用外科杂志，2017年5月；第37卷第5期. |
